Muscle wasting in disease: molecular mechanisms and promising therapies
The DOI matches its Crossref record; 255 of the 257 references it cites were found in a registry or an index.
Abstract
Atrophy occurs in specific muscles with inactivity (for example, during plaster cast immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle wasting occurs systemically in older people (a condition known as sarcopenia); as a physiological response to fasting or malnutrition; and in many diseases, including chronic obstructive pulmonary disorder, cancer-associated cachexia, diabetes, renal failure, cardiac failure, Cushing syndrome, sepsis, burns and trauma. The rapid loss of muscle mass and strength primarily results from excessive protein breakdown, which is often accompanied by reduced protein synthesis. This loss of muscle function can lead to reduced quality of life, increased morbidity and mortality. Exercise is the only accepted approach to prevent or slow atrophy. However, several promising therapeutic agents are in development, and major advances in our understanding of the cellular mechanisms that regulate the protein balance in muscle include the identification of several cytokines, particularly myostatin, and a common transcriptional programme that promotes muscle wasting. Here, we discuss these new insights and the rationally designed therapies that are emerging to combat muscle wasting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence also indicates that RT can effectively mitigate LM or skeletal muscle mass loss associated with dietary interventions (75) and in response to disease states (76).This occurs independently of reductions in body weight and fat mass.”
From Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition? (2024) · cites this paper as [75]
In the citing paper
“The muscle atrophy also occurs in cachexia, a comorbidity of abnormal conditions such as cancer, AIDS, congestive heart failure and chronic obstructive pulmonary disease, also occurs in sarcopenia, a decreases in muscle mass and strength associated with aging [61] .”
From Alternative Medicine: New Ways to Treat Diseases and Therapies (2021) · cites this paper as [61]
In the citing paper
“MuRF1 ubiquitinates several muscle structural proteins, including troponin I, myosin heavy chains, actin, myosin-binding protein C, and myosin light chains 1 and 242.”
From Mechanisms of muscle atrophy and hypertrophy: implications in health and disease (2021) · cites this paper as [42]
In the citing paper
“Because muscle loss requires the activation of transcription‐dependent programme controlled by the regulation of a subset of genes named atrophy‐related genes or atrogenes,36 we monitored several atrogenes mRNAs”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [36]
In the citing paper
“Skeletal muscle mass is controlled by a fine balance between protein synthesis and protein degradation processes triggered by changes in physical activity11,14,15, yet the intrinsic muscular signaling networks driving muscle mass loss particularly during the early phase of muscle disuse remain unclear.”
From Disuse-associated loss of the protease Lonp1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength (2022) · cites this paper as [14]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Items 201–255 of 255
The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice
Caron, A. Z., Haroun, S., Leblanc, É., Trensz, F., Guindi, C., Amrani, A., & Grenier, G. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-185 · Cited by 90
Wang, X. H., Zhang, L., Mitch, W. E., LeDoux, J. M., Hu, J., & Du, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041707 · Cited by 89
Garcia, J. M., & Polvino, W. J. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.12.003 · Cited by 89
Adams, G. R., Haddad, F., Bodell, P. W., Tran, P. D., & Baldwin, K. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00669.2007 · Cited by 88
Diaphragm Muscle Fiber Weakness in Pulmonary Hypertension
de Man, F. S., van Hees, H. W. H., Handoko, M. L., Niessen, H. W., Schalij, I., Humbert, M., Dorfmüller, P., Mercier, O., Bogaard, H.-J., Postmus, P. E., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0354oc · Cited by 86
The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins
Piccirillo, R., & Goldberg, A. L. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.178 · Cited by 85
Self-citationCurran, M. J., & Bihrle, W. (1999) · Urology · doi:10.1016/s0090-4295(98)00348-3 · Cited by 85
Lang, C. H., Huber, D., & Frost, R. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00561.2006 · Cited by 85
Qin, J., Du, R. H., Yang, Y.-Q., Zhang, H., Li, Q., Liu, L., Guan, H., Hou, J., & An, X.-R. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.07.018 · Cited by 82
Effects of hypoxia on capillary density and fiber composition in rat skeletal muscle
Sillau, A. H., & Banchero, N. (1977) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00585531 · Cited by 81
Gene Expression Profiling in Vastus Lateralis Muscle During an Acute Exacerbation of COPD
Crul, T., Testelmans, D., Spruit, M., Troosters, T., Gosselink, R., Geeraerts, I., Decramer, M., & Gayan-Ramirez, G. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000303054 · Cited by 79
Baccarelli, A., Morpurgo, P. S., Corsi, A. M., Vaghi, I., Fanelli, M., Cremonesi, G., Vaninetti, S., Beck‐Peccoz, P., & Spada, A. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00117-6 · Cited by 79
Hurst, J. E., & Fitts, R. H. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00516.2002 · Cited by 77
Hamrick, M. W., Arounleut, P., Kellum, E., Cain, M., Immel, D., & Liang, L.-F. (2010) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e3181c451f4 · Cited by 77
Combaret, L., Tilignac, T., Claustre, A., Voisin, L., Taillandier, D., Obled, C., TANAKA, K., & Attaix, D. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610185 · Cited by 76
The cathepsin L gene is a direct target of FOXO1 in skeletal muscle
Yamazaki, Y., Kamei, Y., Sugita, S., Akaike, F., Kanai, S., Miura, S., Hirata, Y., Troen, B. R., Kitamura, T., Nishino, I., et al. (2010) · Biochemical Journal · doi:10.1042/bj20091346 · Cited by 74
Ryall, J. G., Schertzer, J. D., & Lynch, G. S. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.8.813 · Cited by 69
MST1, a key player, in enhancing fast skeletal muscle atrophy
Wei, B., Dui, W., Liu, D., Xing, Y., Yuan, Z., & Ji, G. (2013) · BMC Biology · doi:10.1186/1741-7007-11-12 · Cited by 68
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction
Supinski, G. S., Vanags, J., & Callahan, L. A. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90404.2008 · Cited by 68
Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD
Doucet, M., Dube, A., Joanisse, D. R., Debigaré, R., Michaud, A., Paré, M., Vaillancourt, R., Fréchette, É., & Maltais, F. (2010) · Thorax · doi:10.1136/thx.2009.133827 · Cited by 67
Hormonal changes in aging men: a therapeutic indication?
Hermann, M., & Berger, P. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00113-9 · Cited by 66
Anti-TNF Treatment Reverts Increased Muscle Ubiquitin Gene Expression in Tumour-Bearing Rats
Llovera, M., Carbó, N., Garcia‐Martínez, C., Costelli, P., Tessitore, L., Baccino, F. M., Agell, N., Bagby, G. J., López-Soriano, F. J., & Argilés, J. M. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0651 · Cited by 66
Coats, A. J. S., Srinivasan, V., Surendran, J., Chiramana, H., Vangipuram, S., Bhatt, N. N., Jain, M. M., Shah, S. A., Ali, I. A. B. H., Ho, G. F., et al. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0046-2 · Cited by 65
Thomas, S. S., & Mitch, W. E. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0729-9 · Cited by 65
New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease
Barnette, M. S., & Underwood, D. C. (2000) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200003000-00014 · Cited by 63
Reed, S. A., Senf, S. M., Cornwell, E. W., Kandarian, S. C., & Judge, S. M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.059 · Cited by 62
Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell Dysfunction
Dong, Y., Pan, J. S., & Zhang, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058554 · Cited by 58
Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice
Murphy, K. T., Cobani, V., Ryall, J. G., Ibebunjo, C., & Lynch, G. S. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01183.2010 · Cited by 58
Wallace, M. A., Hock, M. B., Hazen, B. C., Kralli, A., Snow, R. J., & Russell, A. P. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.205468 · Cited by 56
Nystrom, G. J., & Lang, C. H. (2008) · PubMed · Cited by 54
Sharma, V., Lansdell, T. A., Peddibhotla, S., & Tepe, J. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.006 · Cited by 51
Gonçalves, D. A. P., Lira, E. C., Baviera, A. M., Cao, P., Zanon, N. M., Arany, Z., Bedard, N., Tanksale, P., Wing, S. S., Lecker, S. H., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0428 · Cited by 51
Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects
Watts, R., McAinch, A. J., Dixon, J. B., O'Brien, P. E., & Cameron‐Smith, D. (2013) · Obesity · doi:10.1002/oby.20070 · Cited by 50
PGC-1α and Exercise: Important Partners in Combating Insulin Resistance
Russell, A. (2005) · Current Diabetes Reviews · doi:10.2174/1573399054022811 · Cited by 48
Rel A/p65 is required for cytokine-induced myotube atrophy
Yamaki, T., Wu, C., Gustin, M., Lim, J. K., Jackman, R. W., & Kandarian, S. C. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00111.2012 · Cited by 47
Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy
Hinkle, R. T., Dolan, E., Cody, D. B., Bauer, M. B., & Isfort, R. J. (2005) · Muscle & Nerve · doi:10.1002/mus.20416 · Cited by 46
Prevention of muscle disuse atrophy by MG132 proteasome inhibitor
Jamart, C., Raymackers, J., Li An, G., Deldicque, L., & Francaux, M. (2011) · Muscle & Nerve · doi:10.1002/mus.21949 · Cited by 46
Nonsteroidal Selective Androgen Receptor Modulator Ostarine ™ in Cancer Cachexia
Zilbermint, M. F., & Dobs, A. S. (2009) · Future Oncology · doi:10.2217/fon.09.106 · Cited by 45
PPARβ/δ Regulates Glucocorticoid- and Sepsis-Induced FOXO1 Activation and Muscle Wasting
Castillero, E., Alamdari, N., Aversa, Z., Gurav, A., & Hasselgren, P.-O. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059726 · Cited by 45
Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00242-5 · Cited by 44
Clenbuterol toxicity: a NSW Poisons Information Centre experience
Brett, J., Dawson, A. H., & Brown, J. A. (2014) · The Medical Journal of Australia · doi:10.5694/mja13.10982 · Cited by 43
Smith, I. J., Aversa, Z., Alamdari, N., Petkova, V., & Hasselgren, P.-O. J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22796 · Cited by 40
Acute Quadriplegic Myopathy: An Acquired “Myosinopathy”
Larsson, L. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-84847-1_8 · Cited by 39
Catalano, M. G., Fortunati, N., Arena, K., Costelli, P., Aragno, M., Danni, O., & Boccuzzi, G. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.2.429 · Cited by 37
Baviera, A. M., Zanon, N. M., Navegantes, L. C. C., Migliorini, R. H., & Kettelhut, Í. D. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00147.2006 · Cited by 37
XIAP Reduces Muscle Proteolysis Induced by CKD
Hu, J., Du, J., Zhang, L., Price, S. R., Klein, J. D., & Wang, X. H. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101011 · Cited by 34
Phosphodiesterase‐4 inhibition reduces proteolysis and atrogenes expression in rat skeletal muscles
Lira, E. C., Gonçalves, D. A. P., Parreiras‐E‐Silva, L. T., Zanon, N. M., Kettelhut, I. C., & Navegantes, L. C. C. (2011) · Muscle & Nerve · doi:10.1002/mus.22066 · Cited by 32
Meder, B., Just, S., Vogel, B., Rudloff, J., Gärtner, L., Dahme, T., Huttner, I. G., Zankl, A. R., Katus, H. A., & Rottbauer, W. (2010) · Journal of Cell Science · doi:10.1242/jcs.067967 · Cited by 31
Vissing, K., Rahbek, S. K., Lamon, S., Farup, J., Stefanetti, R. J., Wallace, M. A., Vendelbo, M. H., & Russell, A. P. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.249755 · Cited by 30
Pentoxifylline improves insulin action limiting skeletal muscle catabolism after infection
Vary, T., Dardevet, D. P., Grizard, J., Voisin, L., Buffière, C., Denis, P., Breuillé, D., & Obled, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1630015 · Cited by 29
Vestergaard, E. T., Møller, N., & Jørgensen, J. O. L. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00662.2012 · Cited by 27
Lira, E. C., Graça, F. A., Gonçalves, D. A. P., Zanon, N. M., Baviera, A. M., Strindberg, L., nnroth, P. L., Migliorini, R. H., Kettelhut, Í. D. C., & Navegantes, L. C. C. (2007) · Shock · doi:10.1097/shk.0b013e31802e43a6 · Cited by 22
Insulin-like growth factor-I and analogues increase growth in artificially-reared neonatal pigs
Dunshea, F. R., Chung, C. S., Owens, P. C., Ballard, J. F., & WALTON, P. E. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002574 · Cited by 12
Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro
Pickering, W. P. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg203 · Cited by 10
Insulin-like growth factor-I and analogues increase growth in artificially-reared neonatal pigs
Dunshea, F. R., Chung, C. S., Owens, P. C., Ballard, J. F., & WALTON, P. E. (2002) · British Journal Of Nutrition · doi:10.1079/bjnbjn2002574 · Cited by 4
Research works printed but not linked: 1
- Arany, Z. et al. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35–46 (2007). · DOI · Paper page
Cited by
Nrf2-Keap1 signaling in oxidative and reductive stress
Bellezza, I., Giambanco, I., Minelli, A., & Donato, R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.02.010 · Cited by 2,053
Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
Sartori, R., Romanello, V., & Sandri, M. (2021) · Nature Communications · doi:10.1038/s41467-020-20123-1 · Cited by 940
Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms
Booth, F. W., Roberts, C. K., Thyfault, J. P., Ruegsegger, G. N., & Toedebusch, R. G. (2017) · Physiological Reviews · doi:10.1152/physrev.00019.2016 · Cited by 696
The extracellular matrix protein agrin promotes heart regeneration in mice
Bassat, E., Mutlak, Y. E., Genzelinakh, A., Shadrin, I. Y., Baruch Umansky, K., Yifa, O., Kain, D., Rajchman, D., Leach, J., Riabov Bassat, D., et al. (2017) · Nature · doi:10.1038/nature22978 · Cited by 642
Self-citationUnderstanding cachexia as a cancer metabolism syndrome
Porporato, P. E. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.3 · Cited by 562
Metadata
- Authors
- Cohen, S., Nathan, J. A., & Goldberg, A. L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- University of Cambridge (GB)
- Harvard University (US)
- Corresponding author
- Cohen, Shenhav
- Goldberg, Alfred L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-12-31
- Volume
- 14
- Issue
- 1
- Pages
- 58-74
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1998867833
- Cited by
- 1,089
- References
- 257
- Citations by year
- 2026: 75 · 2025: 92 · 2024: 92 · 2023: 111 · 2022: 110 · 2021: 111 · 2020: 117 · 2019: 88 · 2018: 91 · 2017: 86 · 2016: 79 · 2015: 36
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100140, 102770, 102770/Z/13/Z)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR055255, R01AR055255)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- muscle atrophy, sarcopenia, cancer cachexia, sepsis, denervation, immobilization, protein synthesis, protein degradation, myostatin, cytokines, exercise therapy, therapeutic agents, chronic obstructive pulmonary disease, diabetes mellitus, renal failure, heart failure, Cushing's syndrome
- MeSH terms
- Animals, Humans, Muscular Atrophy, Myofibrils, Quality of Life, Signal Transduction, Sepsis, Wasting Syndrome, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.